Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.
about
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer LesionsThe pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ERMycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal OutcomesA severe case of Buruli ulcer disease with pleural effusionsClinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay.Corticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans.Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patientsMycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.Establishment of quantitative PCR (qPCR) and culture laboratory facilities in a field hospital in benin: 1-year results.Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer diseaseMycobacterial skin and soft tissue infection.Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and BeninTuberculous Meningitis in Children and Adults: A 10-Year Retrospective Comparative Analysis.Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growthGenetic Susceptibility and Predictors of Paradoxical Reactions in Buruli UlcerA genome wide association study identifies a lncRna as risk factor for pathological inflammatory responses in leprosy.Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial.Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.Epidemiology and management of Buruli ulcer.Revisiting Buruli ulcer.Longitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis.Paradoxical response preceding control of Scedosporium apiospermum mycetoma with posaconazole treatment.Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.
P2860
Q24186073-B2E74B57-86FC-4B95-84B1-CC8596BDFA1CQ27318699-7BD794E7-8469-4895-B18C-2614BCBA043EQ28541949-316D38C8-EC5D-46EC-8312-A7FEAA2C5AC9Q28551237-A45030AB-8EB2-43A5-BD02-157307A914F5Q33778730-77748814-F74D-419C-8B5B-2C854E93F617Q34006790-5880B284-BCAF-43AF-AA69-CFED7C2B092EQ34406837-0FB51283-B179-4865-A3F7-AF76D0AFCF7BQ34431496-1ABD4552-C5D2-4566-94CB-C71850413870Q34500901-36F41EE9-0417-443B-80F2-38CA8FEB9165Q34566628-CD839B38-A271-46A6-90A6-B1DDA956FD78Q34855365-9BB071BD-A548-4763-AA3B-FDDC4F7FC22EQ34978950-E618E5DE-B2ED-4EDF-8C87-BF3BE43E2200Q35036322-746D4836-4BC4-4E47-9694-FE1B81DBA1CFQ35145483-5D7AC795-FEE3-4CBF-8535-68603BB8559AQ35359858-4C4A3F52-23A4-4617-9088-06F720654758Q35648325-11778B1D-43E2-43CA-966F-768B4AFB69A9Q35694389-50BCFDB0-6D1F-4868-A252-3FFCFEC3E63EQ35810457-94B25618-68AB-4269-A723-F6DE701579E5Q35911339-43C63D6E-C8F7-46EC-AD82-7E35AEA05644Q35994923-53419E1A-8755-4C18-9B67-17D6F9DA783EQ36286140-9D09C1BC-C9BA-4107-9539-8B7C0D34CB48Q36292804-41CBD8CC-73C2-4CF7-951E-F73DBF323346Q36446126-3CD516DB-3093-4420-99AA-DBEB774744A4Q37166129-80738859-5852-464F-9A0C-BB789683A48EQ37544684-9A391304-7038-4B59-8B76-33CD36797A0FQ38180374-BEEA9182-543D-4466-A237-441A776C093BQ38219419-3B74B410-200C-48B2-A966-EBE3B587B8D0Q38579126-BECD9781-8972-4ED0-B3CD-87A4E3B7189BQ38737488-CE14BA25-909A-4522-8B46-9C158274B81CQ41137884-61B5E11E-436C-4FFC-BE15-50B4DAF525F7Q44703613-750AD85B-26DF-4C30-907B-640D7AD5EBE7Q46241939-4C506D6B-FCD8-4DC1-AAEE-348D11185E40Q51738497-4810AB04-69D1-457A-A391-9E76630ED13AQ53469363-3B8594F0-949D-476F-8442-B2AACD57061D
P2860
Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Paradoxical responses after st ...... obacterium ulcerans infection.
@en
type
label
Paradoxical responses after st ...... obacterium ulcerans infection.
@en
prefLabel
Paradoxical responses after st ...... obacterium ulcerans infection.
@en
P2093
P2860
P356
P1476
Paradoxical responses after st ...... obacterium ulcerans infection.
@en
P2093
Jan P Schouten
K Mohammed Abass
Nana Yaa Awuah-Boateng
Ohene Adjei
Peter C Awuah
Tjip S van der Werf
Willemien A Nienhuis
William A Thompson
Wilson Tuah
Ymkje Stienstra
P2860
P304
P356
10.1093/CID/CIR856
P407
P577
2011-12-07T00:00:00Z